Snowball logo
logo
BCRX_logo

BioCryst Pharmaceuticals Inc

$9.68+$0.13Β  (1.36%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
157.2270.8331.4450.7874.8940.6
COGS
7.2646.5944.66112.4819.07719.4
Gross Profit
149.9264.2326.8438.2855.8221.2
Operating Expenses & Income
Operating Income
(177.7)(148.4)(103.7)(2.543)341(313.2)
Total Operating Expenses
327.6412.7430.5440.8514.8534.7
R&D Expenses
208.8253.3216.6174.6166.1197.8
Selling General & Admin Expenses
113.1144.5199.1252.5348.6337.3
Earnings from Continuing Operations
Interest Expense
(59.29)(99.09)(108.2)(98.52)(78.87)(75.29)
Interest Income
0.0625.12714.0214.7510.677.384
Income Tax Expense
2.2532.7330.311.9273.533.486
Net Income
Net Income
(184.1)(247.1)(226.5)(88.88)263.9(384.7)
Supplemental
EBIT
(122.5)(145.3)(118)11.56346.3(308.9)
EBITDA
(121.7)(143.9)(116.3)12.81347.7(302.9)
In millions of USD, except % and values per 1 share